San Francisco, CA – Genentech is a company we’ve covered quite a few times for their innovative experiences and general attitude toward healthcare. This is no different.
The innovative healthcare company from San Francisco is taking the lead is pushing for some progress in an area of cancer where 95 percent of cases could be prevented or effectively cured if caught early through regular, standard Pap tests and human papillomavirus (HPV) screening. The screenings are now even more accessible due to the Affordable Care Act which enabled young women to stay on their parents insurance plans through the age of 25. The recommended age to start getting screened for Cervical Cancer is 21, so why are we not catching more cases early enough to stop them?
Genentech is sponsoring the Quest Award and their goal is to generate some bold new healthcare solutions that will impact the this fight against cervical cancer. This competition is providing startups an opportunity apply until February 11th. Healthcare is continuing to be disrupted by these small innovative companies over the past few years and it is great to see that being embraced with the creation of things like the Quest Award.